Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis

NCT01331603 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Myelodysplastic Syndrome
Primary Myelofibrosis

Sponsor

Wolfson Medical Center